Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: an emerging initial radiation treatment option for organ …

JC Hodges, Y Lotan, TP Boike, R Benton… - Journal of oncology …, 2012 - ascopubs.org
Purpose: The purpose of this study is to compare the cost-effectiveness of two external beam
radiation therapy techniques for treatment of low-to intermediate-risk prostate cancer …

Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer

A Parthan, N Pruttivarasin, D Davies, DCA Taylor… - Frontiers in …, 2012 - frontiersin.org
Objective: To determine the cost-effectiveness of several external beam radiation treatment
modalities for the treatment of patients with localized prostate cancer. Methods: A lifetime …

Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancer

DJ Sher, RB Parikh, S Mays-Jackson… - American journal of …, 2014 - journals.lww.com
Objectives: Intensity-modulated radiation therapy (IMRT) has been established as the
standard external-beam modality in treating low-risk prostate cancer. Stereotactic body …

Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity

JB Yu, LD Cramer, J Herrin, PR Soulos… - Journal of clinical …, 2014 - ascopubs.org
Purpose Stereotactic body radiation therapy (SBRT) is a technically demanding prostate
cancer treatment that may be less expensive than intensity-modulated radiation therapy …

Dose-escalated stereotactic body radiation therapy for prostate cancer: Quality-of-life comparison of two prospective trials

HC Quon, HB Musunuru, P Cheung, G Pang… - Frontiers in …, 2016 - frontiersin.org
Introduction The optimal prostate stereotactic body radiation therapy (SBRT) dose-
fractionation scheme is controversial. This study compares long-term quality of life (QOL) …

Current use of stereotactic body radiation therapy for low and intermediate risk prostate cancer: A National Cancer Database Analysis

TD Malouff, WC Stross, DS Seneviratne… - Prostate cancer and …, 2020 - nature.com
Background Recent studies have demonstrated both safety and efficacy of stereotactic body
radiation therapy (SBRT) as monotherapy in the treatment of low and intermediate risk …

[HTML][HTML] Multicenter trial of stereotactic body radiation therapy for low-and intermediate-risk prostate cancer: survival and toxicity endpoints

RM Meier, DA Bloch, C Cotrutz, AC Beckman… - International Journal of …, 2018 - Elsevier
Purpose The radiobiology of prostate cancer may favor the extreme hypofractionation
inherent in stereotactic body radiation therapy (SBRT); however, data from a large …

The comparison of stereotactic body radiation therapy and intensity-modulated radiation therapy for prostate cancer by NCCN risk groups

A Ricco, G Manahan, R Lanciano, A Hanlon… - Frontiers in …, 2016 - frontiersin.org
Objectives The primary objective of this study is to compare freedom from biochemical
failure (FFBF) between stereotactic body radiation therapy (SBRT) and intensity-modulated …

Stereotactic body radiotherapy as treatment for organ confined low-and intermediate-risk prostate carcinoma, a 7-year study

AJ Katz, J Kang - Frontiers in oncology, 2014 - frontiersin.org
Objectives: Stereotactic body radiation therapy (SBRT) takes advantage of the prostate's low
α/β ratio to deliver a large radiation dose in few fractions. Initial studies on small groups of …

Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer

JA Halpern, A Sedrakyan, WC Hsu, J Mao… - Cancer, 2016 - Wiley Online Library
BACKGROUND Stereotactic body radiotherapy (SBRT) for localized prostate cancer has
potential advantages over traditional radiotherapies. Herein, the authors compared national …